日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

手术可切除的促纤维增生性黑色素瘤新辅助PD-1阻断治疗：SWOG S1512 II期试验的A组队列

期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-01113-y
Kendra, Kari L; Bellasea, Shay L; Eroglu, Zeynep; Hu-Lieskovan, Siwen; Campbell, Katie M; Carson, William E 3rd; Wada, David A; Plaza, Jose A; In, Gino K; Ikeguchi, Alexandra; Hyngstrom, John; Brohl, Andrew S; Chmielowski, Bartosz; Khushalani, Nikhil I; Markowitz, Joseph; Monroe, Marcus; Contreras, Carlo M; Bowles, Tawnya; Norman, Kurt; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Garcilazo, Ivan Perez; Vega-Crespo, Agustin; Chen, Jia Ming; Deen, Nataly Naser Al; Patel, Sapna P; Grossmann, Kenneth F; Sondak, Vernon K; Sharon, Elad; Moon, James; Wu, Michael C; Ribas, Antoni
黑色素瘤
PD-1
发表日期：2026
文献求助 收藏

Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

抗PD-1疗法治疗不可切除的促纤维增生性黑色素瘤：SWOG S1512 II期试验

期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-025-03875-5.
Kari L Kendra ,Shay L Bellasea ,Zeynep Eroglu ,Siwen Hu-Lieskovan ,Katie M Campbell ,William E Carson 3rd ,David A Wada ,Jose A Plaza ,Jeffrey A Sosman ,Gino K In ,Alexandra Ikeguchi ,John Hyngstrom ,Andrew S Brohl ,Nikhil I Khushalani ,Joseph Markowitz ,George Negrea ,Samer Kasbari ,Gary C Doolittle ,Umang Swami ,Toni Roberts ,Boban N Mathew ,Egmidio Medina ,Ignacio Baselga-Carretero ,Cynthia R Gonzalez ,Ivan Perez Garcilazo ,Agustin Vega-Crespo ,Jia Ming Chen ,Nataly Naser Al-Deen ,Sapna P Patel ,Elad Sharon ,James Moon ,Michael C Wu ,Antoni Ribas
黑色素瘤
PD-1
发表日期：2025
文献求助 收藏

SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low-Tumor Burden Follicular Lymphoma

SWOG 2308：莫苏妥珠单抗与利妥昔单抗治疗低肿瘤负荷滤泡性淋巴瘤的随机III期研究

期刊:
影响因子:
doi:10.1200/OA-25-00037
Ghosh, Nilanjan; Bellasea, Shay; Li, Hongli; Olszewski, Adam J; Bryan, Locke; Danilov, Alexey; Smith, Sonali; LeBlanc, Michael; Friedberg, Jonathan W
肿瘤
淋巴瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1或PD-L1阻断疗法无效的转移性黑色素瘤：一项随机II期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02498-y
VanderWalde, Ari; Bellasea, Shay L; Kendra, Kari L; Khushalani, Nikhil I; Campbell, Katie M; Scumpia, Philip O; Kuklinski, Lawrence F; Collichio, Frances; Sosman, Jeffrey A; Ikeguchi, Alexandra; Victor, Adrienne I; Truong, Thach-Giao; Chmielowski, Bartosz; Portnoy, David C; Chen, Yuanbin; Margolin, Kim; Bane, Charles; Dasanu, Constantin A; Johnson, Douglas B; Eroglu, Zeynep; Chandra, Sunandana; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Garcilazo, Ivan Perez; Sharon, Elad; Hu-Lieskovan, Siwen; Patel, Sapna P; Grossmann, Kenneth F; Moon, James; Wu, Michael C; Ribas, Antoni
PD-L1
黑色素瘤
PD-1
发表日期：2023
文献求助 收藏

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

PARP抑制剂ABT-888（维利帕尼）联合改良FOLFIRI方案与FOLFIRI方案作为转移性胰腺癌二线治疗的随机II期研究：SWOG S1513

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1789
Chiorean, E Gabriela; Guthrie, Katherine A; Philip, Philip A; Swisher, Elizabeth M; Jalikis, Florencia; Pishvaian, Michael J; Berlin, Jordan; Noel, Marcus S; Suga, Jennifer M; Garrido-Laguna, Ignacio; Cardin, Dana Backlund; Radke, Marc R; Duong, Mai; Bellasea, Shay; Lowy, Andrew M; Hochster, Howard S
PARP
胰腺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏